医药导报2024，Vol.43Issue(7)：1127-1134,8.DOI:10.3870/j.issn.1004-0781.2024.07.018
基于VOS-viewer与CiteSpace的癌性疼痛药物研究热点可视化分析
Visual Analysis on Research Hotspots of Cancer Pain Drugs Based on VOS-viewer and CiteSpace
摘要
Abstract
Objective To analyze the research hotspots and trends in the field of cancer pain drugs based on literature.Methods This article included research literature related to cancer pain and drugs published in the China National Knowledge Infrastructure(CNKI)and Web of Science databases.The visual analysis of the literature was performed by software of VOS-viewer 1.6.18 and CiteSpace 6.2.R3,including drawing the graphs and comparing the number of published articles,journals,institutions,authors and keywords were also analyzed.Results A total of 4 774 literatures were included.The journals with the largest number of articles published were the Chinese Journal of Pain Medicine and the Journal of Pain and Symptom Management.The authors with the highest number of articles published were Liu Duanqi and Bruera Eduardo.The institutions with the highest number of publications were Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology,and the University of Texas Anderson Cancer Center.The most frequent keyword was cancer pain.The keywords with the strongest citation bursts included Clinical efficacy average daily cost,and primary care.Conclusion Since the beginning of the 21st century,the research on cancer pain drugs has gradually heated up,and the number of papers has shown an upward trend.From 2019 to 2022,the research on cancer pain drugs at home and abroad mainly focused on the clinical efficacy and average daily cost.This article has clarified the research hotspots of cancer pain drugs in recent years to a certain extent and has certain reference significance for future research.关键词
癌性疼痛/药物/VOS-viewer/CiteSpace/可视化分析Key words
Cancer pain/Drugs/VOS-viewer/CiteSpace/Visual analysis分类
医药卫生引用本文复制引用
张志叶,魏巍,刘维婷,杜慧,兰芝荟,李彤,杨彦彪..基于VOS-viewer与CiteSpace的癌性疼痛药物研究热点可视化分析[J].医药导报,2024,43(7):1127-1134,8.基金项目
甘肃省药品科研项目(2022GSMPA0059) （2022GSMPA0059）
甘肃省药品科研项目(2022GSMPA0060). （2022GSMPA0060）
